NO973107D0 - Programmerte celledödgener og proteiner - Google Patents
Programmerte celledödgener og proteinerInfo
- Publication number
- NO973107D0 NO973107D0 NO973107A NO973107A NO973107D0 NO 973107 D0 NO973107 D0 NO 973107D0 NO 973107 A NO973107 A NO 973107A NO 973107 A NO973107 A NO 973107A NO 973107 D0 NO973107 D0 NO 973107D0
- Authority
- NO
- Norway
- Prior art keywords
- proteins
- cell death
- programmed cell
- death genes
- genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
- F02B75/00—Other engines
- F02B75/02—Engines characterised by their cycles, e.g. six-stroke
- F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
- F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/368,704 US6087160A (en) | 1993-06-24 | 1995-01-04 | Programmed cell death genes and proteins |
PCT/US1996/000177 WO1996020721A1 (en) | 1995-01-04 | 1996-01-04 | Programmed cell death genes and proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
NO973107D0 true NO973107D0 (no) | 1997-07-03 |
NO973107L NO973107L (no) | 1997-08-26 |
Family
ID=23452396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO973107A NO973107L (no) | 1995-01-04 | 1997-07-03 | Programmerte celledödgener og proteiner |
Country Status (10)
Country | Link |
---|---|
US (2) | US6087160A (no) |
EP (1) | EP0808169A4 (no) |
JP (1) | JPH11500304A (no) |
AU (1) | AU4747296A (no) |
CA (1) | CA2209526A1 (no) |
FI (1) | FI972821A (no) |
IL (1) | IL116671A0 (no) |
MX (1) | MX9705039A (no) |
NO (1) | NO973107L (no) |
WO (1) | WO1996020721A1 (no) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025685A1 (en) * | 1992-06-12 | 1993-12-23 | Massachusetts Institute Of Technology | Cloning and characterization of the cell death genes ced-3 and ced-4 |
US6015665A (en) * | 1995-02-13 | 2000-01-18 | The Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
US6060238A (en) * | 1995-02-13 | 2000-05-09 | The Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
US7097972B1 (en) | 1995-02-13 | 2006-08-29 | Regents Of The University Of Michigan | Method and composition for regulating apoptosis |
US7807783B1 (en) | 1995-04-03 | 2010-10-05 | The Regents Of The University Of Michigan | Methods and compositions for regulating FAS-associated apoptosis |
US6747138B1 (en) | 1995-04-03 | 2004-06-08 | Regents Of The University Of Michigan | Methods and compositions for regulating Fas-associated apoptosis |
US6214572B1 (en) * | 1996-08-09 | 2001-04-10 | The General Hospital Corporation | Programmed cell death and ICH-3 |
US5897992A (en) | 1996-09-27 | 1999-04-27 | Cold Spring Harbor Laboratory | Cell-free assay using oncogene-induced apoptosis in drug-resistant cells |
US6184210B1 (en) | 1997-10-10 | 2001-02-06 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
US6342611B1 (en) | 1997-10-10 | 2002-01-29 | Cytovia, Inc. | Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof |
ATE295177T1 (de) * | 1998-03-16 | 2005-05-15 | Cytovia Inc | Dipeptid kaspase inhibitoren und deren verwendung |
WO1999052925A1 (en) | 1998-04-16 | 1999-10-21 | The General Hospital Corporation | Programmed cell death and caspase-12 |
ATE276754T1 (de) | 1998-07-21 | 2004-10-15 | Cytovia Inc | Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung |
KR20010110667A (ko) | 1999-03-16 | 2001-12-13 | 추후보정 | 치환 2-아미노벤즈아미드 카스파제 저해제 및 그것의 용도 |
DE60035037T2 (de) | 1999-04-09 | 2008-01-31 | Cytovia, Inc., San Diego | Caspase inhibitoren und ihre verwendung |
US6462041B1 (en) | 1999-05-21 | 2002-10-08 | Cytovia, Inc. | Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
IL148426A0 (en) | 1999-08-27 | 2002-09-12 | Cytovia Inc | α-HYDROXY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
US6566338B1 (en) | 1999-10-12 | 2003-05-20 | Cytovia, Inc. | Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
CA2390164C (en) | 1999-11-05 | 2011-03-29 | Cytovia, Inc. | Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
WO2001055115A1 (en) | 2000-01-27 | 2001-08-02 | Cytovia, Inc. | Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
CA2406271A1 (en) | 2000-04-18 | 2001-10-25 | Cytovia, Inc. | Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
AU2001278135A1 (en) | 2000-08-03 | 2002-02-18 | Cytovia, Inc. | Method of identifying immunosuppressive agents |
JP4936417B2 (ja) * | 2000-08-03 | 2012-05-23 | オンコセラピー・サイエンス株式会社 | p53依存性新規アポトーシス関連タンパク質、およびアポトーシス調節剤のスクリーニング方法 |
AU2001289068A1 (en) * | 2000-09-20 | 2002-04-02 | Isis Pharmaceuticals, Inc. | Antisense modulation of caspase 2 expression |
US6716851B2 (en) | 2000-12-12 | 2004-04-06 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
EP1392683B1 (en) | 2001-05-16 | 2009-12-02 | Cytovia, Inc. | Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents |
EP1399159A4 (en) * | 2001-06-01 | 2007-02-14 | Cytovia Inc | 4-SUBSTITUTE-1- (ARYLMETHYLIDENE) THIOSEMICARBAZIDE, 4-SUBSTITUTE-1- (ARYLCARBONYL) THIOSEMICARBAZIDE AND ANALOGUES AS ACTIVATORS OF APOPTOSIS CAPSASES AND TRIGS, AND USE THEREOF |
US7041685B2 (en) | 2001-06-08 | 2006-05-09 | Cytovia, Inc. | Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
AU2003230411A1 (en) | 2002-05-16 | 2003-12-02 | Cytovia, Inc. | Substituted 4-aryl-4h-pyrrolo(2,3-h)chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
US7476741B2 (en) | 2002-05-16 | 2009-01-13 | Cytovia, Inc. | Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
JP2006516250A (ja) | 2002-12-18 | 2006-06-29 | サイトビア インコーポレイティッド | カスパーゼ活性化剤およびアポトーシス誘導物質としての3,5−二置換−[1,2,4]−オキサジアゾールおよびそれらの誘導体ならびにそれらの使用 |
CN1984660B (zh) | 2003-07-03 | 2010-12-15 | 美瑞德生物工程公司 | 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉 |
CN1954882A (zh) | 2005-10-14 | 2007-05-02 | 李海 | 长效人重组可溶性肿瘤坏死因子α受体在制备防治肝衰竭药物中的用途 |
ES2848322T3 (es) | 2014-09-09 | 2021-08-06 | Boehringer Ingelheim Animal Health Usa Inc | Líneas celulares de mamífero que expresan receptores de acetilcolina funcionales de nematodos y uso de las mismas para ensayos de cribado de alto rendimiento |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7775991A (en) * | 1990-04-04 | 1991-10-30 | Immunex Corporation | Interleukin 1beta protease |
EP0533350B1 (en) * | 1991-08-16 | 1999-05-26 | Merck & Co. Inc. | DNA encoding precursor interleukin 1B converting enzyme |
HU220098B (hu) * | 1991-08-30 | 2001-10-28 | Vertex Pharmaceuticals Incorporated | Interleukin-1 béta proteáz enzim, és interleukin-1 béta proteáz inhibitorok |
GB9124986D0 (en) * | 1991-11-25 | 1992-01-22 | Greenberg Arnold H | Natural killer cell granule protein |
WO1993025685A1 (en) * | 1992-06-12 | 1993-12-23 | Massachusetts Institute Of Technology | Cloning and characterization of the cell death genes ced-3 and ced-4 |
EP0672151A1 (en) * | 1992-06-12 | 1995-09-20 | Massachusetts Institute Of Technology | Inhibitors of ced-3 and related proteins |
US6083735A (en) * | 1993-06-24 | 2000-07-04 | The General Hospital Corporation | Programmed cell death genes and proteins |
AU7250494A (en) * | 1994-06-23 | 1996-01-19 | Human Genome Sciences, Inc. | Interleukin-1 beta converting enzyme like apoptosis protease-1 and 2 |
-
1995
- 1995-01-04 US US08/368,704 patent/US6087160A/en not_active Expired - Fee Related
- 1995-06-02 US US08/459,455 patent/US20030124105A1/en not_active Abandoned
-
1996
- 1996-01-04 AU AU47472/96A patent/AU4747296A/en not_active Abandoned
- 1996-01-04 EP EP96903363A patent/EP0808169A4/en not_active Withdrawn
- 1996-01-04 JP JP8521228A patent/JPH11500304A/ja active Pending
- 1996-01-04 WO PCT/US1996/000177 patent/WO1996020721A1/en not_active Application Discontinuation
- 1996-01-04 MX MX9705039A patent/MX9705039A/es not_active IP Right Cessation
- 1996-01-04 IL IL11667196A patent/IL116671A0/xx unknown
- 1996-01-04 CA CA002209526A patent/CA2209526A1/en not_active Abandoned
-
1997
- 1997-06-30 FI FI972821A patent/FI972821A/fi unknown
- 1997-07-03 NO NO973107A patent/NO973107L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4747296A (en) | 1996-07-24 |
WO1996020721A1 (en) | 1996-07-11 |
MX9705039A (es) | 1997-10-31 |
EP0808169A4 (en) | 2002-09-11 |
CA2209526A1 (en) | 1996-07-11 |
NO973107L (no) | 1997-08-26 |
JPH11500304A (ja) | 1999-01-12 |
FI972821A0 (fi) | 1997-06-30 |
US6087160A (en) | 2000-07-11 |
EP0808169A1 (en) | 1997-11-26 |
IL116671A0 (en) | 1996-05-14 |
US20030124105A1 (en) | 2003-07-03 |
FI972821A (fi) | 1997-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO973107D0 (no) | Programmerte celledödgener og proteiner | |
EP0711174A4 (en) | REGULATORY GENES OF PROGRAMMED CELL DEATH AND PROTEINS | |
NO985339D0 (no) | Humane B-celleantigener og beslektede reagenser | |
NO943344D0 (no) | MN-gen og -protein | |
EP0852627A4 (en) | CELL DEATH PROTEIN | |
IS5158A (is) | Genaraðgreinir og aðferðir | |
NO934477D0 (no) | PEG hydrazon- og PEG oksim-bindingdannende reagenser og protein-derivater derav | |
NO20071415L (no) | OB-fusjonsproteinpreparater og fremgangsmater | |
IS1810B (is) | Úðablöndur úr peptíðum og próteinum | |
NO980255L (no) | Antiparasittiske marcfortiner og paraherkvamider | |
NO963371D0 (no) | Hematopoeseprotein samt materialer og fremgangsmåter for fremstilling av det | |
EP0847398A4 (en) | COLON-SPECIFIC GENES AND PROTEINS | |
NO20000700D0 (no) | Interleukin-18-proteiner samt fremstilling og anvendelse derav | |
NO20000343D0 (no) | Pattedyr-cytokin:interleukin-B30 og beslektede reagenser | |
DE69602426D1 (de) | Elektrisch betriebener handschläger und -rührer | |
DE69600634D1 (de) | Elektrisch betriebener handschläger und -rührer | |
NO981282D0 (no) | Calcitriolderivater og deres anvendelser | |
DK1310167T3 (da) | Forbedret celleudformning til et trawlsystem og fremgangsmåder | |
GB9516059D0 (en) | Novel genes and proteins | |
AP2001002189A0 (en) | Genes and proteins and their uses | |
NO971505D0 (no) | Trofinin og trofininhjelperproteiner | |
DK0941100T3 (da) | Farmaceutiske præparater indeholdende lamivudin og zidovudin | |
DK0849359T3 (da) | Raffinosesynthetasegener og anvendelsen deraf | |
NO971188D0 (no) | Nye PKA-bindingsproteiner og anvendelse derav | |
IS4676A (is) | Aðferðir og genaferjur fyrir staðbundna endurröðun |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |